首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1486830

全球人造血管市场-市场分析、竞争格局、市场预测（2030年）

Artificial blood vessels - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年05月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

2023 年全球血管移植市场规模为 21.9 亿美元，预计到 2030 年将达到 30.7 亿美元，2024-2030 年预测期间复合年增长率为 5.02%。对血管移植物的需求主要是由老年人口的快速增长和各种心血管疾病盛行率的上升所推动的。此外，由于技术进步、该领域正在进行的大量研究活动、医疗保健提供者、研究人员和行业参与者之间的联盟和战略伙伴关係，预计该市场将成长，预计从2024 年到2030 年将成长。

人造血管市场动态

心血管疾病在世界范围内非常普遍，其中冠状动脉疾病和周围血管疾病所占比例最大。例如，根据美国心臟协会（2022）的数据，2020 年全球约有 2.441 亿人患有冠状动脉心臟病（缺血性心臟病）。同一份文件显示，2020年北非、中东、中亚、南亚和东欧是全球冠心病患病率最高的地区。

根据英国心臟基金会 2022 年的数据，2019 年全球约有 5.5 亿人（每 14 人中就有 1 人）患有心臟和循环系统疾病。据同一消息来源称，2019年，北美有4,103,135人患有心血管疾病，1,089,947人被诊断患有冠状动脉疾病，498,551人患有中风，而在亚洲，有32,376,834人患有心血管疾病。患有冠状动脉疾病，8,111,044人中风。

上述文件进一步指出，冠状动脉心臟病（缺血性）心臟病、週边动脉（血管）疾病、中风和心房颤动仍是2019年全球最常见且流行的心血管疾病。

血管狭窄、闭塞或严重功能障碍是心血管疾病的多种病理生理机转之一。主动脉特别容易受到各种病变的影响，例如腹主动脉瘤、主动脉梗塞和慢性血液透析通路。

血管置换涉及使用人造血管，是治疗闭塞血管结构的首选手术选择。由于健康自体血管的供应有限以及术后併发症的发生率，对血管移植物的需求也在增加。

同样，与新型人造血管开发相关的持续研究活动预计将在短期内加速市场成长。例如，2022 年 9 月，南丹麦大学 (SDU) 和欧登塞大学医院 (OUH) 的研究人员正在致力于开发一种革命性的人造血管，以防止阻塞和感染。

然而，製造和开发血管移植物面临的课题，以及与血管移植物相关的监管合规性和其他安全问题，可能会限制血管移植物市场的整体成长。

人工血管市场区隔分析

在血管移植市场的应用领域，週边动脉疾病类别预计将在 2023 年获得可观的收入占有率。这可能是由于週边动脉疾病的盛行率增加所致。

例如，根据加拿大统计局的最新研究，PAD 在加拿大广泛流行，每年影响约 80 万加拿大人。

此外，与週边动脉疾病相关的年龄、吸烟和高血压等危险因子的增加也进一步推动了血管移植市场的成长。

根据2021年加拿大人口普查，2021年85岁以上的人口数量超过861,000人。文件也指出，从2016年到2021年，85岁及以上的人口数将增加12%，是加拿大总人口成长的两倍多。

本报告研究和分析了全球血管移植市场，提供市场规模和预测、驱动因素和课题、公司和产品概况等。

Artificial Blood Vessels Market By Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, And Others), Application (Aortic Disease, Peripheral Artery Disease, And Hemodialysis), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the prevalence of cardiovascular diseases (CVDS) and increasing research and development activities

The global artificial blood vessels market was valued at USD 2.19 billion in 2023, growing at a CAGR of 5.02% during the forecast period from 2024 to 2030 to reach USD 3.07 billion by 2030. The demand for artificial blood vessels is primarily being boosted by the rising prevalence of various cardiovascular diseases coupled with a rapidly growing geriatric population. Furthermore, the artificial blood vessels market is anticipated to grow on account of the growing technological advancement, a large number of ongoing research activities in this field, collaborations between healthcare providers, researchers, and industry players, and strategic partnerships among others are going to contribute in the overall growth of the artificial blood vessels market during the forecast period from 2024-2030.

Artificial Blood Vessels Market Dynamics:

Cardiovascular diseases are highly prevalent across the globe, of which the largest proportion is taken by coronary and peripheral vascular diseases. For instance, according to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020. As per the same source, North Africa, the Middle East, Central and South Asia, and Eastern Europe had the highest prevalence rates of coronary (ischemic) heart disease in the world in 2020.

As per the data provided by British Heart Foundation 2022, worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men. As per the same source, in 2019, in North America, cardiovascular diseases affected 4,103,135 people, 1,089,947 people were diagnosed with coronary artery disease, and 498,551 suffered from stroke; In Asia, there were 32,376,834 people diagnosed with cardiovascular diseases, from which 12,543,833 individuals were affected by coronary artery disease, and 8,111,044 population was suffered from a stroke.

The source mentioned above further stated that coronary (ischemic) heart disease (200 million cases), peripheral arterial (vascular) disease (110 million cases), stroke (100 million cases), and atrial fibrillation (60 million cases) remained the commonest and prevalent cardiovascular conditions worldwide in 2019.

Stenosis, occlusion, or severe dysfunction of blood vessels are among various pathophysiological mechanisms of cardiovascular diseases. The aorta tends to be affected by a range of disease conditions including abdominal aortic aneurysm, coarctation of the aorta, and chronic hemodialysis access among others.

For the treatment of obstructed vascular structures, vascular replacement involving the usage of artificial blood vessels is the preferred surgical option. The demand for artificial blood vessels is also on the rise due to the limited availability of healthy autologous vessels as well as the incidence of postoperative complications.

Similarly, ongoing research activities about the development of novel artificial blood vessels will accelerate market growth in the foreseeable future. For example, in September 2022, University of Southern Denmark (SDU) and Odense University Hospital (OUH) researchers are working on the development of a revolutionary artificial blood vessel that is prevented from closing or becoming infected.

However, regulatory compliance and other safety concerns associated with artificial blood vessels along with challenges encountered during manufacturing and development of artificial blood vessels may restrict the growth of the overall artificial blood vessels market.

Artificial Blood Vessels Market Segment Analysis:

Artificial Blood Vessels Market by Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, and Others), Application (Aortic Disease, Peripheral Artery Disease, and Hemodialysis), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the application segment of the artificial blood vessels market, the peripheral artery disease category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the rising prevalence of peripheral artery disease.

For instance, as per the latest study provided by Statistic Canada, PAD is widely prevalent in the country, affecting approximately 800,000 Canadians, every year.

Also, the rise in the number of risk factors such as old age, smoking, hypertension, and others associated with peripheral artery disease is further boosting the market growth for artificial blood vessels.

As per the Canadian Census 2021, over 861,000 people aged 85 and older were counted in 2021. The aforesaid source also stated that, between 2016 and 2021, the number of people aged 85 and older grew by 12%, which is more than twice as high as the growth seen for the overall Canadian population.

According to the facts and figures provided by WHO in 2022, it was estimated that in Spain, almost every fifth of adults and adolescents smoke.

The same source stated that almost 18% of adults smoked tobacco in the year 2020 and 21% of adolescents aged 15-16 smoked cigarettes in 2019. The increasing consumption of tobacco and smoking among adults and youngsters will make them more prone to cardiovascular disorders such as PAD, and others.

By replacing the damaged native blood vessels, artificial blood vessels help to treat severe cases of peripheral artery disease.

Therefore, owing to the above-mentioned factors, the peripheral artery disease category is expected to register significant growth, thereby driving the growth of the overall artificial blood vessels market during the forecast period.

North America Is Expected To Dominate The Overall Artificial Blood Vessels Market:

Among all the regions, North America is estimated to account for the largest share of the Artificial Blood Vessels market in the year 2023. Owing to the significance of key growth factors such as the increased mortality rate due to aortic aneurysm, rise in cases of peripheral artery disease and coronary artery diseases among other cardiovascular disease conditions, growing awareness programs and initiatives related to heart health, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for artificial blood vessels is expected to witness prosperity in the region during the forecast period 2024-2030.

The Centers for Disease Control and Prevention (CDC) 2021 highlighted that aortic aneurysms or aortic dissections were responsible for causing about 9,904 deaths in 2019 in the United States. As per the same source, 59% of those deaths occurred among men. The number of deaths due to aortic aneurysms could have been avoided with proper surgical treatment via the utilization of artificial blood vessels.

As per the Centers for Disease Control and Prevention 2022, approximately 6.5 million people aged 40 and older were there with peripheral artery disease (PAD) condition in 2021 in the United States.

Another factor contributing to the growth of the artificial blood vessels market is the continued rise in the number of individuals involved in smoking. For instance, as per the Centers for Disease Control and Prevention 2022, approximately 40 million people smoke cigarettes in the US. As per the same source, every day nearly 1,600 US youth aged 18 years or younger smoke their first cigarette. Smoking increases the risk for a range of cardiovascular disease conditions.

Thus, the above-mentioned factors are likely to propel the growth of the artificial blood vessels market in the region during the forecast period from 2024-2030.

Artificial Blood Vessels Market Key Players:

Some of the key market players operating in the Artificial Blood Vessels market include LeMaitre Vascular Inc., Terumo Medical Corporation, W. L. Gore and Associates, B. Braun SE, Roumai Med, Jiangsu Bioda Life Science Co. Ltd., Artivion, Inc., Getinge, Vygon, and others.

Recent Developmental Activities In The Artificial Blood Vessels Market:

In November 2022, Jiangsu Bioda Life Science Co. Ltd.'s artificial blood vessel gained class III medical device approval from China's NMPA, marking the first domestic artificial blood vessel to get such approval. Nantong, China-based Bioda's vessel is used for aortic coarctation and aneurysms.

Key Takeaways From The Artificial Blood Vessels Market Report Study

Market size analysis for current artificial blood vessels market size (2023), and market forecast for 6 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global artificial blood vessels market.
Various opportunities available for the other competitors in the artificial blood vessels market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current artificial blood vessels market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for artificial blood vessel market growth in the coming future?

Target Audience Who Can Be Benefited From This Artificial Blood Vessels Market Report Study

Artificial Blood Vessels product providers
Research organizations and consulting companies
Artificial Blood Vessels -related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders dealing in artificial blood vessels
Various End-users who want to know more about the artificial blood vessels market and the latest technological developments in the artificial blood vessels market.

Frequently Asked Questions For The Artificial Blood Vessels Market:

1. What are artificial blood vessels?

Artificial blood vessels are represented as ideal vascular grafts that are composed of viable tissues. They offer advantages including compliance, lack of thrombogenicity, and resistance to infections among others.

2. What is the market for global artificial blood vessels?

The artificial blood vessels market was valued at USD 2.19 billion in 2023, growing at a CAGR of 5.02% during the forecast period from 2024 to 2030 to reach USD 3.07 billion by 2030.

3. What are the drivers for the global artificial blood vessels market?

The demand for artificial blood vessels is primarily being boosted by the increasing patient population suffering from various heart conditions benefits of artificial blood vessels for vascular obstruction, and continuous innovation in product development among others, thereby contributing to the overall growth of the Artificial Blood Vessels market during the forecast period from 2024-2030.

4. Who are the key players operating in the global artificial blood vessels market?

Some of the key market players operating in the artificial blood vessels market include LeMaitre Vascular Inc., Terumo Medical Corporation, W. L. Gore and Associates, B. Braun SE, Roumai Med, Jiangsu Bioda Life Science Co. Ltd., Artivion, Inc., Getinge, Vygon, and others.

5. Which region has the highest share in the artificial blood vessels market?

North America is expected to dominate the overall artificial blood vessels market during the forecast period from 2024-2030. Owing to factors such as the rise in the number of people with cardiovascular diseases, the surge in the number of awareness programs and initiatives for heart health, high disposable income, sophisticated healthcare infrastructure, and high awareness among others, North American artificial blood vessels market is expected to growth in coming years.

1. Artificial Blood Vessels Market Report Introduction

1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption

2. Artificial Blood Vessels Market Executive Summary

2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

4.1. The United States
4.2. Europe
4.3. Japan
4.4. China

5. Artificial Blood Vessels Market Key Factors Analysis

5.1. Artificial Blood Vessels Market Drivers
- 5.1.1. The increasing prevalence of cardiovascular diseases (CVDs) coupled with the surge in risk factors such as old age, smoking, and others associated with causing CVDs
- 5.1.2. Technological innovations in product development
- 5.1.3. Collaboration between researchers, healthcare professionals, and industry players
5.2. Artificial Blood Vessels Market Restraints and Challenges
- 5.2.1. Regulatory compliance and other safety concerns associated with artificial blood vessels
- 5.2.2. Challenges encountered during manufacturing and development of artificial blood vessels
5.3. Artificial Blood Vessels Market Opportunities
- 5.3.1. Surge in the number of research activities associated with the development of artificial blood vessels
- 5.3.2. Advances in bioengineering techniques

6. Artificial Blood Vessels Market Porter's Five Forces Analysis

6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry

7. Artificial Blood Vessels Market Layout

7.1. By Polymer Type
- 7.1.1. Polydioxanone
- 7.1.2. Elastomer
- 7.1.3. Polyethylene Terephthalate
- 7.1.4. Others
7.2. By Application
- 7.2.1. Aortic Disease
- 7.2.2. Peripheral Artery Disease
- 7.2.3. Hemodialysis
7.3. By Geography
- 7.3.1. North America
  - 7.3.1.1. United States Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.1.2. Canada Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.1.3. Mexico Artificial Blood Vessels Market Size in USD million (2021-2030)
- 7.3.2. Europe
  - 7.3.2.1. France Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.2. Germany Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.3. United Kingdom Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.4. Italy Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.5. Spain Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.2.6. Rest of Europe Artificial Blood Vessels Market Size in USD million (2021-2030)
- 7.3.3. Asia-Pacific
  - 7.3.3.1. China Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.2. Japan Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.3. India Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.4. Australia Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.5. South Korea Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.3.6. Rest of Asia-Pacific Artificial Blood Vessels Market Size in USD million (2021-2030)
- 7.3.4. Rest of the World (RoW)
  - 7.3.4.1. Middle East Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.4.2. Africa Artificial Blood Vessels Market Size in USD million (2021-2030)
  - 7.3.4.3. South America Artificial Blood Vessels Market Size in USD million (2021-2030)

8. Artificial Blood Vessels Market Company and Product Profiles

8.1. B. Braun SE
- 8.1.1. Company Overview
- 8.1.2. Company Snapshot
- 8.1.3. Financial Overview
- 8.1.4. Product Listing
- 8.1.5. Entropy
8.2. Terumo Medical Corporation
- 8.2.1. Company Overview
- 8.2.2. Company Snapshot
- 8.2.3. Financial Overview
- 8.2.4. Product Listing
- 8.2.5. Entropy
8.3. Roumai Med
- 8.3.1. Company Overview
- 8.3.2. Company Snapshot
- 8.3.3. Financial Overview
- 8.3.4. Product Listing
- 8.3.5. Entropy
8.4. Jiangsu Bioda Life Science Co. Ltd
- 8.4.1. Company Overview
- 8.4.2. Company Snapshot
- 8.4.3. Financial Overview
- 8.4.4. Product Listing
- 8.4.5. Entropy
8.5. W. L. Gore & Associates, Inc.
- 8.5.1. Company Overview
- 8.5.2. Company Snapshot
- 8.5.3. Financial Overview
- 8.5.4. Product Listing
- 8.5.5. Entropy
8.6. LeMaitre Vascular Inc.
- 8.6.1. Company Overview
- 8.6.2. Company Snapshot
- 8.6.3. Financial Overview
- 8.6.4. Product Listing
- 8.6.5. Entropy
8.7. Artivion, Inc
- 8.7.1. Company Overview
- 8.7.2. Company Snapshot
- 8.7.3. Financial Overview
- 8.7.4. Product Listing
- 8.7.5. Entropy
8.8. Getinge
- 8.8.1. Company Overview
- 8.8.2. Company Snapshot
- 8.8.3. Financial Overview
- 8.8.4. Product Listing
- 8.8.5. Entropy
8.9. Vygon
- 8.9.1. Company Overview
- 8.9.2. Company Snapshot
- 8.9.3. Financial Overview
- 8.9.4. Product Listing
- 8.9.5. Entropy